Dynamics of Blood Electrolytes in Repeated Hyper- And/or Hypoglycaemic Events in Patients with Type 1 Diabetes
Overview
Affiliations
Aims/hypothesis: Electrolyte disturbances are well-known consequences of the diabetic pathology. However, less is known about the cumulative effects of repeated changes in glycaemia, a characteristic of diabetes, on the electrolyte balance. We therefore investigated the ionic profiles of patients with type 1 diabetes during consecutive hyper- and/or hypoglycaemic events using the glucose clamp.
Methods: In protocol 1, two successive hyperglycaemic excursions to 18 mmol/l were induced; in protocol 2, a hypoglycaemic excursion (2.5 mmol/l) was followed by a hyperglycaemic excursion (12 mmol/l) and another hypoglycaemic episode (3.0 mmol/l).
Results: Blood osmolarity increased during hyperglycaemia and was unaffected by hypoglycaemia. Hyperglycaemia induced decreases in plasma Na(+) Cl(-) and Ca(2+) concentrations and increases in K(+) concentrations. These changes were faithfully reproduced during a second hyperglycaemia. Hypoglycaemia provoked rapid and rapidly reversible increases in Na(+), Cl(-) and Ca(2+). In sharp contrast, K(+) levels displayed a rapid and substantial fall from which they did not fully recover even 2 h after the re-establishment of euglycaemia. A second hypoglycaemia caused an additional fall.
Conclusions/interpretation: Repeated hyperglycaemia events do not lead to any cumulative effects on blood electrolytes. However, repeated hypoglycaemias are cumulative with respect to K(+) levels due to a very slow recovery following hypoglycaemia. These results suggest that recurring hypoglycaemic events may lead to progressively lower K(+) levels despite rapid re-establishment of euglycaemia. This warrants close monitoring of plasma K(+) levels combined with continuous glucose monitoring particularly in patients under intensive insulin therapy who are subject to repeated hypoglycaemic episodes.
Trial Registration: Clinicaltrial.gov NCT01060917.
Insight into continuous glucose monitoring: from medical basics to commercialized devices.
Chmayssem A, Nadolska M, Tubbs E, Sadowska K, Vadgma P, Shitanda I Mikrochim Acta. 2023; 190(5):177.
PMID: 37022500 DOI: 10.1007/s00604-023-05743-w.
Hameed S, Arshad M, Ahmad R, Hussain G, Arshad M, Ahmed A Lipids Health Dis. 2020; 19(1):78.
PMID: 32326942 PMC: 7178752. DOI: 10.1186/s12944-020-01223-9.
Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management.
VanBaak K, Nally L, Finigan R, Jurkiewicz C, Burnier A, Conrad B Wilderness Environ Med. 2019; 30(4S):S121-S140.
PMID: 31753543 PMC: 7510348. DOI: 10.1016/j.wem.2019.10.003.
Continuous noninvasive glucose monitoring; water as a relevant marker of glucose uptake in vivo.
Caduff A, Ben Ishai P, Feldman Y Biophys Rev. 2019; 11(6):1017-1035.
PMID: 31741172 PMC: 6874943. DOI: 10.1007/s12551-019-00601-7.
Kim S, Kwak C, Jung J, Baek J, Jung J, Park K Biomed Res Int. 2018; 2018:8692078.
PMID: 30105256 PMC: 6076964. DOI: 10.1155/2018/8692078.